No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
DRC – The government of the Democratic Republic of Congo (DRC), has received US$59.7 million from the Global Alliance for Vaccines and Immunization (GAVI’s) Equity Accelerator Fund to help reduce…
Read More
AFRICA— 18 million doses of the first ever malaria vaccine, RTS,S/AS01, will be allocated to 9 more African Countries, in addition to Ghana, Kenya and Malawi, who are currently finalising…
Read More
ERITREA— The Expanded Program for the Immunization Department of the Ministry of Health (MoH) Eritrea, in partnership with several development partners has conducted a large-scale HPV Multi-Aged Cohort (HPV-MAC) vaccination…
Read More
NIGERIA—Dr. Muhammad Pate, former Minister of State for Health in Nigeria, has declined the Global Alliance Vaccines Initiative (GAVI) CEO position, GAVI has confirmed. In February 2023, Pate was confirmed…
Read More
ETHIOPIA—The African Union Commission (AUC) and the Global Alliance for Vaccines and Immunization (GAVI) have signed a Memorandum of Understanding (MOU), towards the acceleration of vaccines across African Union member…
Read More
SWITZERLAND — Gavi, the Vaccine Alliance, has unveiled a roadmap that outlines critical actions required to address the current shortage of oral cholera vaccine (OCV) and meet the growing demand…
Read More
AFRICA – Gavi, the Vaccine Alliance has announced the appointment of Dr Muhammad Ali Pate as its new Chief Executive Officer. Dr Pate will assume the role as of 3…
Read More
AFRICA – Gavi, the Vaccine Alliance, has announced the appointment of African immunologist, parasitologist and malariologist Rose Gana Fomban Leke as the new chair of its independent review committee (IRC).…
Read More
SWITZERLAND — Gavi, the Vaccine Alliance has launched the Innovation for Uptake, Scale, and Equity in Immunization (INFUSE) 2.0, a scaling hub for innovation to accelerate immunization system upgrades in…
Read More
SWITZERLAND — The Board of Gavi, the Vaccine Alliance today approved an evolution of its current 5-year program strategy that will see renewed focus on routine immunization and reaching zero-dose…
Read More